The global pandemic caused by the coronavirus has had far-reaching and long-lasting impacts. The disease's entire breadth has yet to be discovered. Initially, there were multiple anecdotal and published reports of eye redness and irritation in COVID-19 patients, implying that conjunctivitis is an ocular symptom of SARS-CoV-2 infection. COVID-19 has been linked to uveitic, retinovascular, and neuro-ophthalmic illness, according to new research. Based on the findings in the patients' eyes, it's been indicated that unprotected eyes can also become infected with the SAR-CoV-2 virus. The drugs used to treat COVID-19 have ocular side effects as well. Although long-term treatment of chloroquine and hydroxychloroquine can cause retinal damage, this is neither expected or seen with COVID-19.
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : White-dot syndrome like presentation secondary to ibrutinib therapy : A case report
Shailja Chalishazar, Cardiff and Vale University Health Board, United Kingdom
Title : The usual suspects: Bilateral astrocytic hamartomas in tuberous sclerosis
Nishi Meghna Satish, VMMC & Safdarjung Hospital, India
Title : Knowledge, attitude and practice of diabetic retinopathy amongst diabetic patients in a tertiary care hospital in jammu north india
Pallavi Sharma, Govt. Medical college Jammu, University of Jammu, India
Title : To compare Anesthetic efficacy and pupillary dilation dynamics of combined vs. standard topical regime in phacoemulsification surgery
Kanavdeep Kapoor, ASCOMS, Jammu, India
Title : A study on ocular morbidities in children aged between 7 to 18 years attending ophthalmology OPD in Al Ameen Medical College and Hospital Bijapur
Ayesha Batool, Al Ameen Medical College and Hospital Bijapur, India